Skip to main content

Table 2 Laboratory, clinical and imaging findings of the 10 study patients with brucellar spondylitis at the end of treatment

From: Fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scan contributes to the diagnosis and management of brucellar spondylodiskitis

Pt Duration of treatment (months) Findings at the end of treatment Duration of follow-up after treatment discontinuation (months)
ESR mm/hr CRP mg/L SAT titers WBC K/μl Clinical MRI residual findings F-18 FDG PET/CT findings F-18 FDG PET/CT SUVmax
1 12 40 5.00 1/320 4.70 (−) L5 – S1 L2 – L3, L5 – S1 3.2 2.6 27
2 12 10 5.00 1/680 6.50 (−) T7 – T8 T7 – T8, L4 – L5 3.3 2.0 13
3 9 5 3.08 1/ 10240 4.43 (−) L2 – L3 L3 2.9 21
4 12 35 10.00 1/320 6.65 (−) L4 – L5 L5 T6 2.6 2.9 10
5 6 15 2.97 < 1/160 7.24 (−) (−) (−) 0 9
6 11 15 2.97 1/320 5.15 Back pain on effort L4 – L5 L4 – L5 2.7 8
7 12 17 3.08 < 1/160 7.85 Pain on weather changes (−) T7 2.0 17
8 12 20 4.10 < 1/160 8.90 (−) (−) L3 2.0 11
9 6 14 5.00 < 1/160 7.70 (−) (−) L3 3.0 21
10 12 23 5.00 < 1/160 4.80 Back pain on effort L4 – L5 L1 – L2, L4 – L5 2.9 4.4 12
  1. NOTES. Pt: patient number, ESR: erythrocyte sedimentation rate (normal value, 40 mm/hour), CRP: C-reactive protein (normal values < 5 mg/L), WBC: white blood count, SAT: slide agglutination test (normal values < 1/160), MRI: magnetic resonance imaging, F-18 FDG PET/CT: fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography combined with computed tomography scan, SUVmax: maximum standard uptake value.